Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.8, 2009-08, pp. : 987-1012

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies

Current Cancer Drug Targets, Vol. 16, Iss. 9, 2016-10 ,pp. : 755-764

Bentham Science Publishers

Access to resources Recommend Favorite

Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 938-952

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Concepts on Inhibitors of Indoleamine 2,3-Dioxygenase in Rheumatic Diseases

Current Medicinal Chemistry, Vol. 19, Iss. 31, 2012-11 ,pp. : 5381-5393

Bentham Science Publishers

Access to resources Recommend Favorite

Indoleamine 2,3-dioxygenase, Tregs and Cancer

Current Medicinal Chemistry, Vol. 18, Iss. 15, 2011-05 ,pp. : 2240-2246

Bentham Science Publishers

Access to resources Recommend Favorite

Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases

Current Medicinal Chemistry, Vol. 18, Iss. 15, 2011-05 ,pp. : 2257-2262

Bentham Science Publishers

Access to resources Recommend Favorite